Your browser doesn't support javascript.
loading
Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial.
Wu, Zhi-Wei; Jin, Fei; Li, Qing-Liang; Gao, Jia-Mei; Zhou, Hai-Song; Duan, Kai; Gao, Zhao; Liu, Yan; Hao, Zhi-Yong; Chen, Wei; Liu, Yue-Yue; Xu, Ge-Lin; Yang, Biao; Dong, Ben; Zhang, Jiu-Wei; Zhao, Yu-Liang; Yang, Xiao-Ming.
  • Wu ZW; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
  • Jin F; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
  • Li QL; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
  • Gao JM; National Institutes for Food and Drug Control, Beijing, China.
  • Zhou HS; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China.
  • Duan K; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
  • Gao Z; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
  • Liu Y; National Institutes for Food and Drug Control, Beijing, China.
  • Hao ZY; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China.
  • Chen W; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
  • Liu YY; National Institutes for Food and Drug Control, Beijing, China.
  • Xu GL; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
  • Yang B; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
  • Dong B; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
  • Zhang JW; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
  • Zhao YL; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
  • Yang XM; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.
Hum Vaccin Immunother ; 19(2): 2263228, 2023 08.
Article en En | MEDLINE | ID: mdl-37843437
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Rotavirus / Rotavirus / Vacunas contra Rotavirus Límite: Humans / Infant Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Rotavirus / Rotavirus / Vacunas contra Rotavirus Límite: Humans / Infant Idioma: En Año: 2023 Tipo del documento: Article